Literature DB >> 28761975

Interim FDG-PET in lymphoma, a questionable practice in hematology.

Hugo J A Adams1, Thomas C Kwee2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28761975     DOI： 10.1007/s00259-017-3783-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  21 in total

Review 1.  Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Authors:  B D Cheson; S J Horning; B Coiffier; M A Shipp; R I Fisher; J M Connors; T A Lister; J Vose; A Grillo-López; A Hagenbeek; F Cabanillas; D Klippensten; W Hiddemann; R Castellino; N L Harris; J O Armitage; W Carter; R Hoppe; G P Canellos
Journal:  J Clin Oncol       Date:  1999-04       Impact factor: 44.544

2.  Diffuse Large B-Cell Lymphoma Version 1.2016.

Authors:  Andrew D Zelenetz; Leo I Gordon; William G Wierda; Jeremy S Abramson; Ranjana H Advani; C Babis Andreadis; Nancy Bartlett; John C Byrd; Luis E Fayad; Richard I Fisher; Martha J Glenn; Thomas M Habermann; Nancy Lee Harris; Francisco Hernandez-Ilizaliturri; Richard T Hoppe; Steven M Horwitz; Mark S Kaminski; Christopher R Kelsey; Youn H Kim; Susan Krivacic; Ann S LaCasce; Matthew Lunning; Auayporn Nademanee; Pierluigi Porcu; Oliver Press; Rachel Rabinovitch; Nishitha Reddy; Erin Reid; Kenneth Roberts; Ayman A Saad; Lubomir Sokol; Lode J Swinnen; Julie M Vose; Joachim Yahalom; Nadeem Zafar; Mary Dwyer; Hema Sundar
Journal:  J Natl Compr Canc Netw       Date:  2016-02       Impact factor: 11.908

3.  SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma.

Authors:  René-Olivier Casasnovas; Michel Meignan; Alina Berriolo-Riedinger; Stéphane Bardet; Anne Julian; Catherine Thieblemont; Pierre Vera; Serge Bologna; Josette Brière; Jean-Philippe Jais; Corinne Haioun; Bertrand Coiffier; Franck Morschhauser
Journal:  Blood       Date:  2011-04-25       Impact factor: 22.113

4.  Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  M Dreyling; M Ghielmini; S Rule; G Salles; U Vitolo; M Ladetto
Journal:  Ann Oncol       Date:  2017-12-01       Impact factor: 32.976

5.  Poor predictive value of positive interim FDG-PET/CT in primary mediastinal large B-cell lymphoma.

Authors:  Julien Lazarovici; Marie Terroir; Julia Arfi-Rouche; Jean-Marie Michot; Sacha Mussot; Valentina Florea; Maria-Rosa Ghigna; Peggy Dartigues; Cynthia Petrovanu; Alina Danu; Christophe Fermé; Vincent Ribrag; David Ghez
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-21       Impact factor: 9.236

6.  Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma.

Authors:  Craig H Moskowitz; Heiko Schöder; Julie Teruya-Feldstein; Camelia Sima; Alexia Iasonos; Carol S Portlock; David Straus; Ariela Noy; Maria L Palomba; Owen A O'Connor; Steven Horwitz; Sarah A Weaver; Jessica L Meikle; Daniel A Filippa; James F Caravelli; Paul A Hamlin; Andrew D Zelenetz
Journal:  J Clin Oncol       Date:  2010-03-08       Impact factor: 44.544

7.  Revised response criteria for malignant lymphoma.

Authors:  Bruce D Cheson; Beate Pfistner; Malik E Juweid; Randy D Gascoyne; Lena Specht; Sandra J Horning; Bertrand Coiffier; Richard I Fisher; Anton Hagenbeek; Emanuele Zucca; Steven T Rosen; Sigrid Stroobants; T Andrew Lister; Richard T Hoppe; Martin Dreyling; Kensei Tobinai; Julie M Vose; Joseph M Connors; Massimo Federico; Volker Diehl
Journal:  J Clin Oncol       Date:  2007-01-22       Impact factor: 44.544

8.  Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.

Authors:  Bruce D Cheson; Richard I Fisher; Sally F Barrington; Franco Cavalli; Lawrence H Schwartz; Emanuele Zucca; T Andrew Lister
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

9.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

Review 10.  Hodgkin's lymphoma: the pathologist's viewpoint.

Authors:  S A Pileri; S Ascani; L Leoncini; E Sabattini; P L Zinzani; P P Piccaluga; A Pileri; M Giunti; B Falini; G B Bolis; H Stein
Journal:  J Clin Pathol       Date:  2002-03       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.